Diabetes Medication: SGLT2 Inhibitors Slash Alzheimer’s Risk by 43%!

Since July 16, the Dexcom Flex has been available in Germany, specifically targeting adults with Type 2 diabetes.

Target Group: Individuals over 18 years old managing their metabolism with basal insulin, oral antidiabetics, or GLP-1 receptor agonists. The system transmits glucose values in real-time to smartphones or smartwatches.

One significant advantage: the elimination of routine finger pricks. The sensors not only provide current data but also offer personalized insights into glucose trends. Warning functions protect against impending hypoglycemia.

Clear Benefits Supported by Studies

Clinical data support the broader use of Continuous Glucose Monitoring (CGM) in Type 2 diabetics. Numerous studies indicate a significant reduction in HbA1c levels, the central marker for metabolic control.

Furthermore, the “Time in Range” improves remarkably. Patients spend more time with stable glucose levels, reducing the risk of diabetic complications.

Experts observe additional positive effects, such as fewer hospitalizations and reduced cardiovascular risks. Continuous monitoring seems to make a genuine difference.

Recent NIH evaluation shows that SGLT2 inhibitors reduce the risk of Alzheimer’s disease by 43 percent. Discover how to protect your brain and benefit from cutting-edge therapies in this free report. Request your free report now

Diabetes Medications with Surprising Additional Benefits

Alongside technological advancements, new data provides exciting insights about diabetes medications. An NIH analysis from July 2026 indicates that SGLT2 inhibitors could lower Alzheimer’s risk by 43%. GLP-1 agonists also show a noteworthy reduction of 33%.

This development is complemented by the pTau217 blood test for early Alzheimer’s detection, now available in the EU.

Furthermore, a high-dose oral version of Semaglutide (25 mg) is in the pharmaceutical pipeline, which could further expand therapeutic options.

Diabetes affects mental health—risk of depression increases by 60%. However, there are ways to strengthen both body and spirit. This report outlines how nutrition, early detection, and modern medications work together. Secure your report on diabetes and brain protection

Sugar Tax Coming in 2028

These medical advances are accompanied by health policy measures. To prevent metabolic diseases, the German government plans to introduce a sugar tax in 2028 aimed at incentivizing healthier diets.